aminolevulinic acid has been researched along with 2019 Novel Coronavirus Disease in 8 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Headache is common in PRES, though headache associated with PRES was not identified as a separate entity in the 2018 International Classification of Headache Disorders." | 2.72 | Posterior Reversible Encephalopathy Syndrome. ( Gao, V; Gewirtz, AN; Parauda, SC; Robbins, MS, 2021) |
| "Associations with PRES include renal failure, preeclampsia and eclampsia, autoimmune conditions, and immunosuppression." | 2.72 | Posterior Reversible Encephalopathy Syndrome. ( Gao, V; Gewirtz, AN; Parauda, SC; Robbins, MS, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, G | 1 |
| Jiang, M | 1 |
| Cui, Z | 1 |
| Sun, X | 1 |
| Chen, T | 1 |
| Wang, Z | 1 |
| Saheb Sharif-Askari, N | 1 |
| Soares, NC | 1 |
| Mohamed, HA | 1 |
| Saheb Sharif-Askari, F | 1 |
| Alsayed, HAH | 1 |
| Al-Hroub, H | 1 |
| Salameh, L | 1 |
| Osman, RS | 1 |
| Mahboub, B | 1 |
| Hamid, Q | 1 |
| Semreen, MH | 1 |
| Halwani, R | 1 |
| Nara, E | 1 |
| Lai, HW | 1 |
| Imazato, H | 1 |
| Ishizuka, M | 1 |
| Nakajima, M | 1 |
| Ogura, SI | 1 |
| Tanaka, T | 1 |
| Tashiro, M | 1 |
| Ota, K | 1 |
| Fujita, A | 1 |
| Sawai, T | 1 |
| Kadota, J | 1 |
| Fukuda, Y | 1 |
| Sumiyoshi, M | 1 |
| Ide, S | 1 |
| Tachikawa, N | 1 |
| Fujii, H | 1 |
| Hibino, M | 1 |
| Shiomi, H | 1 |
| Izumida, M | 1 |
| Matsui, K | 1 |
| Yamauchi, M | 1 |
| Takahashi, K | 1 |
| Yamanashi, H | 1 |
| Sugimoto, T | 1 |
| Akabame, S | 1 |
| Umeda, M | 1 |
| Shimizu, M | 1 |
| Hosogaya, N | 1 |
| Kosai, K | 1 |
| Takeda, K | 1 |
| Iwanaga, N | 1 |
| Ashizawa, N | 1 |
| Hirayama, T | 1 |
| Takazono, T | 1 |
| Yamamoto, K | 1 |
| Imamura, Y | 1 |
| Miyazaki, T | 1 |
| Kobayashi, Y | 1 |
| Ariyoshi, K | 1 |
| Mukae, H | 1 |
| Yanagihara, K | 1 |
| Kita, K | 2 |
| Izumikawa, K | 1 |
| Comentale, G | 1 |
| Manzo, R | 1 |
| Pilato, E | 1 |
| Gewirtz, AN | 1 |
| Gao, V | 1 |
| Parauda, SC | 1 |
| Robbins, MS | 1 |
| Kobayashi, E | 1 |
| Sakurai, Y | 1 |
| Ngwe Tun, MM | 1 |
| Kurosaki, Y | 1 |
| Sakura, T | 1 |
| Inaoka, DK | 1 |
| Fujine, K | 1 |
| Morita, K | 1 |
| Yasuda, J | 1 |
1 review available for aminolevulinic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Posterior Reversible Encephalopathy Syndrome.
Topics: Acute Chest Syndrome; Aminolevulinic Acid; Anemia, Sickle Cell; Autoimmune Diseases; Blood-Brain Bar | 2021 |
1 trial available for aminolevulinic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Safety and efficacy of 5-aminolevulinic acid phosphate/iron in mild-to-moderate coronavirus disease 2019: A randomized exploratory phase II trial.
Topics: Aminolevulinic Acid; COVID-19; Humans; Iron; Phosphates; Prospective Studies; SARS-CoV-2 | 2023 |
6 other studies available for aminolevulinic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Construction of 5-aminolevulinic acid synthase variants by cysteine-targeted mutation to release heme inhibition.
Topics: 5-Aminolevulinate Synthetase; Aminolevulinic Acid; COVID-19; Cysteine; Heme; Hemin; Humans; Mutation | 2022 |
Saliva metabolomic profile of COVID-19 patients associates with disease severity.
Topics: Aminolevulinic Acid; Biomarkers; C-Reactive Protein; Chromatography, Liquid; COVID-19; Humans; Kynur | 2022 |
Suppression of angiotensin converting enzyme 2, a host receptor for SARS-CoV-2 infection, using 5-aminolevulinic acid in vitro.
Topics: Aminolevulinic Acid; Angiotensin-Converting Enzyme 2; COVID-19; Humans; Porphyrins; SARS-CoV-2 | 2023 |
Sars-Cov-2 interference in HEME production: is it the time for an early predictive biomarker?
Topics: Aminolevulinic Acid; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Heme; Host-Patho | 2020 |
Testing of human equivalent dose of health food 5-aminolevulinic acid using the experimental pig.
Topics: Aminolevulinic Acid; Animals; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; F | 2021 |
5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro.
Topics: Aminolevulinic Acid; Animals; Antiviral Agents; Caco-2 Cells; Chlorocebus aethiops; Citric Acid; COV | 2021 |